Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

No reported Change in Working Capital figures are available to summarize.

Change in Working Capital history

Currency unavailable · from the cash flow

No Change in Working Capital data reported for this period type.

Change in Working Capital vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Change in Working Capital for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYTKCytokinetics, IncorporatedLTM Jun 2026$4.77M USD+1.2%+13.0%6.7%
TNYATenaya Therapeutics, Inc.LTM Mar 2026$3.6M USD-53.4%+42.5%1601.8%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$1.32M USD-263.2%-31.1%—
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$247K USD-98.8%—3.5%
RNAAtrium Therapeutics, Inc.FY2025$200K USD——1.1%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-76.1%+13.0%5.1%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.